Solid Dosage
GEA offers a complete range of technologies for the high-volume production of solid OTC Painkillers, Analgesics and Fever Relief products
The fast and reliable release of active ingredients is becoming increasingly important, particularly for analgesic drugs. Customer expectations of over-the-counter (OTC) painkillers are “fast and effective” results for immediate relief. At the same time, these dosage forms need to be easy to take and relatively inexpensive.
Beyond rapid action, for example, the benefits of effervescent tablets include an opportunity for formulators to improve the taste of their oral dosage form, a less aggressive delivery method and the consumer appeal associated with taking a fizzy tablet.
Plus, with various market players now developing combination (bilayer) drugs, the need for commercial-scale double-sided rotary tablet presses has never been greater. Designed for the reliable and cost-effective large-scale production of oral solid dosage forms, GEA’s portfolio includes models that combine the benefits of flexibility and robust performance for a wide range of formulations.
Experts in every aspect of high-volume batch processing, GEA offers a complete range of technologies for the production of solid dosage forms: from powder handling to granulating, drying, tablet compression and coating. And, from R&D through scale-up to commercial production, we can identify the most appropriate solution for your specific application and meet your technical requirements.
GEA’s entire range of process equipment is designed with system integration in mind. A modular approach allows customers to select standard process modules to suit their needs. Furthermore, our rotary tablet presses provide a number of options for the high-volume production of large tablets, including continuous manufacturing in low humidity environments.
30 の 4 を表示する
GEA の革新的な CIP コンセプトは、包括的な最高規格を満たしています。当社のエキスパートは、プロセスのあらゆる時点で、製品の安全性を保証しています。どのアップグレードも、現場の個々の条件および顧客の要件に適合し、顕著な節約を実現します。
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Competitively priced with short delivery times, BUCK® valves are fully GMP compliant, offer robust, free-oriented docking, a dust- and contamination-free interface, and quick and easy maintenance. And, with thousands of global implementations and 20 years of experience.
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
健康で幸せな乳牛は、持続可能な生乳生産を成功させる鍵です。したがって、乳牛を健康に保つことは、すべての酪農家の取り組みの中心にあります。個々の乳牛のニーズに合わせた適切な給餌、良好な飼育環境、新鮮な空気、水、光など、多くの要因が乳牛の健康に影響を与えます。しかし同時に、搾乳方法は乳牛の健康状態に大きな影響を与えます。GEAは「Good Cow Milking」の理念でよく知られており、家畜の健康と乳質においてより良い結果を出すために、常にさら...
どの業界も、厳しい脱炭素規制や法規制を乗り越えながら、ネットゼロの目標達成に向けて懸命に取り組んでいます。同時に、企業は、品質、製品開発、プロセスの最適化に対する高まる要求のバランスを取りながら、収益性の向上に努めなければなりません。この課題には、GEAが提供するような協調的かつ包括的なアプローチが必要です。
コーヒー、カカオ、牛乳、肉、魚、卵。こういった毎日の定番ともいえる食材は、集約農業に大きく依存しています。ニューフード技術の台頭に伴い、これまで以上に持続可能な代替食品を使用できるようになりました。そこで今回は、GEA で液体・発酵・充填担当上級副社長を務めるライマー・グッテ博士と対談し、その可能性と政策について探ってみました。